Gufic BioSciences Ltd (GUFICBIO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 338998, "name": "Gufic BioScience", "stock_name": "Gufic BioScience", "full_name": "Gufic BioSciences Ltd", "name_url": "stocks-analysis/gufic-bioscience", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "350.00", "chg": -13.4, "chgp": "-3.69%", "dir": -1, "prev_price": "363.40", "mcapval": "3,670.00 Cr", "mcap": "Small Cap", "scripcode": 509079, "symbol": "GUFICBIO", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE742B01025", "curr_date": "Jun 11, 04:01 PM", "curr_time": "16:49 PM", "last_traded_at": "Jun 11, 04:01 PM IST", "bse_nse_vol": "1.28 lacs", "exc_status": "Active", "traded_date": "Jun 11, 2026", "traded_date_str": "2026 06 11", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gufic-bioscience-338998-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Gufic BioSciences Ltd Valuation Shifts Signal Price Attractiveness Change Amid Sector Dynamics", "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-valuation-shifts-signal-price-attractiveness-change-amid-sector-dynamics-4045690", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GuficBioScience_valuationdot_4045690.png", "date": "2026-06-11 08:00:18", "description": "Gufic BioSciences Ltd has witnessed a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change reflects evolving market perceptions and impacts the stock’s price attractiveness relative to its historical levels and peer group within the Pharmaceuticals & Biotechnology sector." }, { "title": "Gufic BioSciences Ltd Upgraded to Hold as Financial and Technical Trends Improve", "link": "https://www.marketsmojo.com/news/stock-recommendation/gufic-biosciences-ltd-upgraded-to-hold-as-financial-and-technical-trends-improve-4035390", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GuficBioScience_mojoScore_4035390.png", "date": "2026-06-04 08:07:40", "description": "Gufic BioSciences Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a marked improvement in its financial performance and technical indicators. The upgrade, effective from 3 June 2026, follows a positive quarterly report for March 2026 and a shift in technical trends, signalling cautious optimism for investors in this small-cap pharmaceutical player." }, { "title": "Gufic BioSciences Ltd Shows Technical Momentum Shift Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-shows-technical-momentum-shift-amid-mixed-indicator-signals-4035161", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GuficBioScience_technicaldot_4035161.png", "date": "2026-06-04 08:01:19", "description": "Gufic BioSciences Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance, supported by a blend of positive and cautious signals across key technical indicators. This development comes alongside a significant 3.73% gain in the stock price, reflecting renewed investor interest in the pharmaceuticals and biotechnology sector." }, { "title": "Gufic BioSciences Ltd Shows Mixed Technical Signals Amid Sideways Momentum Shift", "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-shows-mixed-technical-signals-amid-sideways-momentum-shift-4032736", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GuficBioScience_technicaldot_4032736.png", "date": "2026-06-03 08:01:10", "description": "Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Recent technical indicators present a complex picture, with weekly signals suggesting mild bullishness while monthly metrics remain bearish, reflecting a nuanced market sentiment for the stock priced at ₹349.95 as of 3 June 2026." }, { "title": "Gufic BioSciences Ltd Sees Mixed Technical Signals Amid Mildly Bearish Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-sees-mixed-technical-signals-amid-mildly-bearish-momentum-4029251", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GuficBioScience_technicaldot_4029251.png", "date": "2026-06-02 08:02:34", "description": "Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a 3.67% gain on 2 June 2026, the company’s technical indicators present a complex picture, with some weekly signals showing mild bullishness while monthly trends remain bearish. This article analyses the recent technical parameter changes, key momentum indicators, and the implications for investors." }, { "title": "Gufic BioSciences Surges 14.30%: Technical Recovery Amid Financial Struggles", "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-surges-1430-technical-recovery-amid-financial-struggles-4024135", "imagepath": "", "date": "2026-05-31 09:00:06", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>25 May:</strong> Intraday high with 7.34% surge to Rs.314.50</p>\n <p><strong>26 May:</strong> Mojo rating upgraded from Strong Sell to Sell</p>\n <p><strong>27 May:</strong> Technical momentum shifts to sideways trend amid mixed signals</p>\n <p><strong>29 May:</strong> Week closes at Rs.334.90, up 14.30% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.293.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.334.90</..." }, { "title": "Gufic BioSciences Q4 FY26: Strong Profit Surge Masks Valuation Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/gufic-biosciences-q4-fy26-strong-profit-surge-masks-valuation-concerns-4024495", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GuficBioScience_quaterlyResult_4024495.png", "date": "2026-05-30 22:48:29", "description": "Gufic BioSciences Ltd. reported a remarkable 183.68% year-on-year surge in net profit to ₹21.90 crores for Q4 FY26, significantly outperforming its ₹7.72 crores profit in the corresponding quarter last year. The Mumbai-based pharmaceutical company, with a market capitalisation of ₹3,222 crores, demonstrated robust operational momentum with revenue climbing 22.83% YoY to ₹251.82 crores, though the stock's premium valuation at 67 times trailing earnings raises concerns about sustainability." }, { "title": "Gufic BioSciences Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges", "link": "https://www.marketsmojo.com/news/stock-recommendation/gufic-biosciences-ltd-upgraded-to-sell-on-technical-improvements-despite-financial-challenges-4015807", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GuficBioScience_mojoScore_4015807.png", "date": "2026-05-27 08:04:46", "description": "Gufic BioSciences Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 26 May 2026, reflecting a nuanced shift in technical indicators despite ongoing financial challenges. The company’s technical trend has improved from mildly bearish to sideways, while valuation and financial trends continue to weigh on investor sentiment amid a challenging operating environment." }, { "title": "Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-4015628", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GuficBioScience_technicaldot_4015628.png", "date": "2026-05-27 08:01:29", "description": "Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a day decline of 2.54%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious investor sentiment amid evolving market dynamics." } ], "total": 568, "sid": "338998", "stock_news_url": "https://www.marketsmojo.com/news/gufic-biosciences-338998" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "05-Jun-2026", "details": "Written Transcript of Earnings Conference Call held on June 01 2026 at 04:30 PM is attached herewith.", "source": "BSE" }, { "caption": "Corrigendum And Clarification To Intimation Dated May 29 2026 Regarding Subscription To Shares Of Saraswat Co-Operative Bank Limited", "datetime": "02-Jun-2026", "details": "Corrigendum and Collaboration to Intimation dated May 29 2026 regarding Subscription to Shares of Saraswat Co-operative Bank Limited is attached herewith", "source": "BSE" }, { "caption": "Corrigendum And Clarification To Intimation Dated May 29 2026 Regarding Subscription To Shares Of Saraswat Co-Operative Bank Limited", "datetime": "02-Jun-2026", "details": "Corrigendum and Clarification to Intimation dated May 29 2026 regarding Subscription to Shares of Saraswat Co-operative Bank Limited is attached herewith", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Gufic BioSciences Ltd has declared <strong>10%</strong> dividend, ex-date: 22 Sep 25", "dt": "2025-09-22", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

25 May: Intraday high with 7.34% surge to Rs.314.50

26 May: Mojo rating upgraded from Strong Sell to Sell

27 May: Technical momentum shifts to sideways trend amid mixed signals

29 May: Week closes at Rs.334.90, up 14.30% for the week

Week Open

Rs.293.00

Week Close

Rs.334.90Read full news article

Gufic BioSciences Q4 FY26: Strong Profit Surge Masks Valuation Concerns

2026-05-30 22:48:29

Gufic BioSciences Ltd. reported a remarkable 183.68% year-on-year surge in net profit to ₹21.90 crores for Q4 FY26, significantly outperforming its ₹7.72 crores profit in the corresponding quarter last year. The Mumbai-based pharmaceutical company, with a market capitalisation of ₹3,222 crores, demonstrated robust operational momentum with revenue climbing 22.83% YoY to ₹251.82 crores, though the stock's premium valuation at 67 times trailing earnings raises concerns about sustainability.

Read full news article

Gufic BioSciences Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges

2026-05-27 08:04:46

Gufic BioSciences Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 26 May 2026, reflecting a nuanced shift in technical indicators despite ongoing financial challenges. The company’s technical trend has improved from mildly bearish to sideways, while valuation and financial trends continue to weigh on investor sentiment amid a challenging operating environment.

Read full news article

Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-27 08:01:29

Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a day decline of 2.54%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious investor sentiment amid evolving market dynamics.

Read full news article